Awards for “TEVA PHARMACEUTICALS USA, INC.”
25 awards on this page · sorted by amount · page 8
| Award ID | Recipient | Awarding agency | Amount | Start | End | NAICS | Description |
|---|---|---|---|---|---|---|---|
| SPE2DP25F6737 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $495.47K | 2025-05-12 | 2025-05-20 | 325412 | 8511369396!ADENOVIRUS TYPE 4 A |
| SPE2DP25F5524 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $495.47K | 2025-04-07 | 2025-04-29 | 325412 | 8511296200!ADENOVIRUS TYPE 4 A |
| SPE2DP25F4432 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $495.47K | 2025-03-06 | 2025-03-25 | 325412 | 8511229347!ADENOVIRUS TYPE 4 A |
| SPE2DP24F8000 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $476.41K | 2024-09-18 | 2024-09-24 | 325412 | 8510902352!ADENOVIRUS TYPE 4 A |
| SPE2DP24F7999 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $476.41K | 2024-09-18 | 2024-09-24 | 325412 | 8510902161!ADENOVIRUS TYPE 4 A |
| SPE2DP24F7172 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $476.41K | 2024-08-22 | 2024-08-27 | 325412 | 8510839915!ADENOVIRUS TYPE 4 A |
| SPE2DP24F6267 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $476.41K | 2024-07-19 | 2024-07-30 | 325412 | 8510767027!ADENOVIRUS TYPE 4 A |
| SPE2DP24F6264 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $476.41K | 2024-07-19 | 2024-07-30 | 325412 | 8510766969!ADENOVIRUS TYPE 4 A |
| SPE2DP24F5487 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $476.41K | 2024-06-13 | 2024-06-25 | 325412 | 8510688488!ADENOVIRUS TYPE 4 A |
| SPE2DP24F5486 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $476.41K | 2024-06-13 | 2024-06-25 | 325412 | 8510688487!ADENOVIRUS TYPE 4 A |
| SPE2DP24F5485 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $476.41K | 2024-06-13 | 2024-06-25 | 325412 | 8510688484!ADENOVIRUS TYPE 4 A |
| SPE2DP24F4772 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $476.41K | 2024-05-15 | 2024-05-21 | 325412 | 8510634430!ADENOVIRUS TYPE 4 A |
| SPE2DP24F3915 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $476.41K | 2024-04-09 | 2024-04-30 | 325412 | 8510559075!ADENOVIRUS TYPE 4 A |
| SPE2DP24F3914 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $476.41K | 2024-04-09 | 2024-04-30 | 325412 | 8510559073!ADENOVIRUS TYPE 4 A |
| SPE2DP24F3174 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $476.41K | 2024-03-13 | 2024-03-26 | 325412 | 8510500535!ADENOVIRUS TYPE 4 A |
| SPE2DP24F3171 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $476.41K | 2024-03-13 | 2024-03-26 | 325412 | 8510500487!ADENOVIRUS TYPE 4 A |
| SPE2DP24F2831 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $476.41K | 2024-02-22 | 2024-02-27 | 325412 | 8510462402!ADENOVIRUS TYPE 4 A |
| SPE2DP24F2826 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $476.41K | 2024-02-22 | 2024-02-27 | 325412 | 8510462400!ADENOVIRUS TYPE 4 A |
| SPE2DP24F2003 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $476.41K | 2024-01-25 | 2024-01-30 | 325412 | 8510401751!ADENOVIRUS TYPE 4 A |
| SPE2DP24F1991 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $476.41K | 2024-01-25 | 2024-01-30 | 325412 | 8510401470!ADENOVIRUS TYPE 4 A |
| SPE2DP24F1235 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $458.09K | 2023-12-14 | 2023-12-19 | 325412 | 8510325470!ADENOVIRUS TYPE 4 A |
| SPE2DP23F6114 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $458.09K | 2023-09-12 | 2023-09-19 | 325412 | 8510134778!ADENOVIRUS TYPE 4 A |
| SPE2DP23F6113 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $458.09K | 2023-09-11 | 2023-09-19 | 325412 | 8510134580!ADENOVIRUS TYPE 4 A |
| SPE2DP23F5673 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $458.09K | 2023-08-22 | 2023-08-29 | 325412 | 8510093094!ADENOVIRUS TYPE 4 A |
| SPE2DP23F3966 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $458.09K | 2023-05-17 | 2023-05-23 | 325412 | 8509896045!ADENOVIRUS TYPE 4 A |